Stallergenes Greer in brief
Stallergenes Greer is a leading global biopharmaceutical company specialising in allergy, through the development and commercialisation of allergen immunotherapy (AIT) products and services for their diagnosis and treatment.
Stallergenes Greer has an extensive global footprint, and the largest allergen and finished AIT product manufacturing capacity globally. The company’s extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets), offers patients innovative solutions to improve the life for people with allergies.
With around 1,200 employees, Stallergenes Greer has a global presence in 45 countries through its subsidiaries, manufacturing sites, and distribution network.